Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Rolls-Royce picked to build UK small nuclear reactors

(Sharecast News) - Rolls-Royce has been selected to build small modular nuclear reactors in the UK, after a competition run by the government to reduce Britain's reliance on fossil fuels.

Great British Energy on Tuesday announced Rolls preferred bidder for the programme. The announcement was made as the government pledged £14.2bn to build the large Sizewell C power station in Suffolk.

Nuclear power is expected to feature heavily in Finance Minister Rachel Reeves' spending review tomorrow, amid embarrassment over the U-turn to axe winter fuel payments for pensioners and arguments over funding for police forces around the country.

Rolls beat competition from the US companies Holtec and GE Hitachi, while the Canadian-owned Westinghouse withdrew from the competition earlier.

"The truth is that we have this massive challenge to get off fossil fuels. That is the central driving ambition of the government's clean energy superpower mission. We know that we're going to have to see electricity demand at least double, by 2050," said Energy Secretary Ed Miliband.

"All of the expert advice says nuclear has a really important role to play in the energy system. In any sensible reckoning, this is essential to get to our clean power and net zero ambitions."

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.